APA (7th ed.) Citation

HJ, W., NHY, L., YH, T., BSY, Y., KZX, T., YN, T., . . . CH, S. (2025). Anti-diabetic effects of GLP-1 receptor agonists on obese and overweight patients across diabetes status, administration routes, treatment duration and baseline characteristics: A systematic review. Diabetes, obesity & metabolism, 27(4), 1648. https://doi.org/10.1111/dom.16136

Chicago Style (17th ed.) Citation

HJ, Wong, et al. "Anti-diabetic Effects of GLP-1 Receptor Agonists on Obese and Overweight Patients Across Diabetes Status, Administration Routes, Treatment Duration and Baseline Characteristics: A Systematic Review." Diabetes, Obesity & Metabolism 27, no. 4 (2025): 1648. https://doi.org/10.1111/dom.16136.

MLA (9th ed.) Citation

HJ, Wong, et al. "Anti-diabetic Effects of GLP-1 Receptor Agonists on Obese and Overweight Patients Across Diabetes Status, Administration Routes, Treatment Duration and Baseline Characteristics: A Systematic Review." Diabetes, Obesity & Metabolism, vol. 27, no. 4, 2025, p. 1648, https://doi.org/10.1111/dom.16136.